Drug coated balloon (DCB) angioplasty significantly reduces reintervention rates in patients with symptomatic femoropopliteal peripheral artery disease (PAD). However, stand‐alone DCB use in long, severely calcified lesions is frequently associated… Click to show full abstract
Drug coated balloon (DCB) angioplasty significantly reduces reintervention rates in patients with symptomatic femoropopliteal peripheral artery disease (PAD). However, stand‐alone DCB use in long, severely calcified lesions is frequently associated with vessel recoil and/or high‐grade dissections necessitating provisional stent implantation.
               
Click one of the above tabs to view related content.